BR9307347A - Derivados de 5-hidrazino-quinolina antimicrobianos - Google Patents

Derivados de 5-hidrazino-quinolina antimicrobianos

Info

Publication number
BR9307347A
BR9307347A BR9307347A BR9307347A BR9307347A BR 9307347 A BR9307347 A BR 9307347A BR 9307347 A BR9307347 A BR 9307347A BR 9307347 A BR9307347 A BR 9307347A BR 9307347 A BR9307347 A BR 9307347A
Authority
BR
Brazil
Prior art keywords
hydrazino
antimicrobial
quinoline derivatives
quinoline
derivatives
Prior art date
Application number
BR9307347A
Other languages
English (en)
Inventor
Thomas Prosser Demuth
Ronald Eugene White
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of BR9307347A publication Critical patent/BR9307347A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Quinoline Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
BR9307347A 1992-10-30 1993-10-22 Derivados de 5-hidrazino-quinolina antimicrobianos BR9307347A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96896092A 1992-10-30 1992-10-30
PCT/US1993/010091 WO1994010163A1 (en) 1992-10-30 1993-10-22 Antimicrobial 5-hydrazino-quinolone derivatives

Publications (1)

Publication Number Publication Date
BR9307347A true BR9307347A (pt) 1999-05-25

Family

ID=25514997

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9307347A BR9307347A (pt) 1992-10-30 1993-10-22 Derivados de 5-hidrazino-quinolina antimicrobianos

Country Status (21)

Country Link
EP (1) EP0666853A1 (pt)
JP (1) JPH08502750A (pt)
KR (1) KR950704301A (pt)
CN (1) CN1064357C (pt)
AU (1) AU687018B2 (pt)
BR (1) BR9307347A (pt)
CA (1) CA2148003A1 (pt)
CZ (1) CZ282581B6 (pt)
EG (1) EG20543A (pt)
FI (1) FI952049A7 (pt)
HU (1) HUT72072A (pt)
IL (1) IL107323A (pt)
MX (1) MX9306814A (pt)
NO (1) NO951640L (pt)
NZ (1) NZ257470A (pt)
PL (1) PL178094B1 (pt)
RU (1) RU2126000C1 (pt)
SG (1) SG59979A1 (pt)
SK (1) SK54795A3 (pt)
WO (1) WO1994010163A1 (pt)
ZA (1) ZA938089B (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5646163A (en) * 1992-10-30 1997-07-08 The Procter & Gamble Company Quinolone 5-(N-heterosubstituted amino) antimicrobials
CA2196539C (en) * 1994-08-02 2001-05-15 The Procter & Gamble Company Process for making quinolonyl lactam antimicrobials and novel intermediate compounds
WO1996004247A1 (en) * 1994-08-02 1996-02-15 The Procter & Gamble Company Process for making antimicrobial compounds
ATE229950T1 (de) * 1996-02-09 2003-01-15 Toyama Chemical Co Ltd Chinolin carbonsaure-derivate und ihre salze
RU2248199C1 (ru) * 2003-06-02 2005-03-20 Открытое Акционерное Общество "Акционерное Курганское общество медицинских препаратов и изделий "Синтез" (ОАО "Синтез") Глазные капли и способ их получения
RU2265437C2 (ru) * 2003-07-02 2005-12-10 Суханов Александр Владимирович Способ лечения заболеваний желудка и двенадцатиперстной кишки, вызванных helicobacter pylori
RU2245134C1 (ru) * 2003-09-02 2005-01-27 Открытое акционерное общество "Красфарма" Состав офлоксацина для инъекций
WO2005026147A1 (ja) 2003-09-10 2005-03-24 Kyorin Pharmaceutical Co., Ltd. 7−(4−置換−3−シクロプロピルアミノメチル−1−ピロリジニル)キノロンカルボン酸誘導体
US8546423B2 (en) 2005-05-18 2013-10-01 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
EP2594272B1 (en) * 2005-05-18 2018-07-11 Horizon Orphan LLC Aerosolized fluoroquinolones and uses thereof
CA2528849C (en) 2005-06-08 2014-01-14 Janssen Pharmaceutica N.V. Quinoline derivatives as antibacterial agents
EA010601B1 (ru) * 2005-06-09 2008-10-30 Янссен Фармацевтика Н.В. Производные хинолина в качестве антибактериальных агентов
CN101020647B (zh) * 2007-02-14 2011-03-30 杭州师范学院 一种β-环丙胺基丙烯酸(酯)的合成方法
JP5363350B2 (ja) * 2007-03-19 2013-12-11 武田薬品工業株式会社 Mapk/erkキナーゼ阻害剤
US7928100B2 (en) * 2007-10-05 2011-04-19 Cylene Pharmaceuticals, Inc. Quinolone analogs and methods related thereto
MX2010012855A (es) * 2008-06-03 2010-12-21 Actelion Pharmaceuticals Ltd Derivados de [4-(1-amino-etil)-ciclohexil]-metil-amina y [6-(1-amino-etil)-tetrahidro-piran-3-il]-metil-amina como antibacterianos.
KR101959873B1 (ko) 2008-10-07 2019-03-19 랩터 파마슈티컬스 인코포레이티드 약동학 개선을 위한 에어로졸 플루오로퀴놀론 제형
CA2739893C (en) 2008-10-07 2016-10-04 Mpex Pharmaceuticals, Inc. Inhalation of levofloxacin for reducing lung inflammation
AR076222A1 (es) * 2009-04-09 2011-05-26 Actelion Pharmaceuticals Ltd Derivados 2-hidroxietil-1h-quinolin-ona y sus analogos azaisotericos con actividad antibacteriana y composiciones farmaceuticas que los contienen
WO2011029059A1 (en) 2009-09-04 2011-03-10 Mpex Pharmaceuticals, Inc. Use of aerosolized levofloxacin for treating cystic fibrosis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4668680A (en) * 1985-12-12 1987-05-26 Warner-Lambert Company 5-amino-6,8-difluoroquinolones as antibacterial agents
JPH0228178A (ja) * 1988-04-23 1990-01-30 Toyama Chem Co Ltd 新規なピリドンカルボン酸誘導体およびその塩並びにそれらの製造法
DE3906365A1 (de) * 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
WO1991002526A1 (en) * 1989-08-16 1991-03-07 Pfizer Inc. Azabicyclo quinolone carboxylic acids
ES2147721T3 (es) * 1990-04-18 2000-10-01 Procter & Gamble Pharma Quinolonil lactamas antimicrobianas.
DK0559774T3 (da) * 1990-11-30 2000-01-31 Warner Lambert Co Individuelle stereoisomerer af 7-/3-(1-aminoalkyl)-1-pyrrolidinal/-quinoloner og naphthyridoner som antibakterielle midler

Also Published As

Publication number Publication date
IL107323A0 (en) 1994-01-25
WO1994010163A1 (en) 1994-05-11
HU9501237D0 (en) 1995-06-28
MX9306814A (es) 1994-07-29
AU5409794A (en) 1994-05-24
NO951640L (no) 1995-06-30
PL308671A1 (en) 1995-08-21
RU2126000C1 (ru) 1999-02-10
AU687018B2 (en) 1998-02-19
CN1064357C (zh) 2001-04-11
CN1092773A (zh) 1994-09-28
CA2148003A1 (en) 1994-05-11
IL107323A (en) 2000-06-01
SG59979A1 (en) 1999-02-22
CZ109795A3 (en) 1995-12-13
ZA938089B (en) 1994-06-07
JPH08502750A (ja) 1996-03-26
EG20543A (en) 1999-07-31
RU95110762A (ru) 1997-01-10
NO951640D0 (no) 1995-04-28
FI952049A0 (fi) 1995-04-28
EP0666853A1 (en) 1995-08-16
PL178094B1 (pl) 2000-02-29
NZ257470A (en) 1997-08-22
HUT72072A (en) 1996-03-28
KR950704301A (ko) 1995-11-17
CZ282581B6 (cs) 1997-08-13
FI952049L (fi) 1995-04-28
FI952049A7 (fi) 1995-04-28
SK54795A3 (en) 1995-12-06

Similar Documents

Publication Publication Date Title
FI930208L (fi) Kinazolinderivat
FI935431A7 (fi) Kiantsoliinijohdannaisia
FI980341L (fi) 2-oksi-indolijohdannaisia
ATA75293A (de) Indolderivate
FI933037A7 (fi) Tiazolylvinylfenylderivat
FI935805A7 (fi) Oksadiatsiinijohdannaiset
FI941423A7 (fi) 17beta-substituoidut 4-atsa-5alfa-androstan-3-onijohdannaiset
BR9307347A (pt) Derivados de 5-hidrazino-quinolina antimicrobianos
NO920103D0 (no) Antibakterielle midler
DE69330497D1 (de) Chinazolin-derivate
FI20010214L (fi) Asyyliaminoindolijohdannaisia
KR950700911A (ko) 살균약제로서의 치환된 3-피롤리디닐티오-카르바페넴(Substituted 3-Pyrrolidinylthio-Carbapenems as Antimicrobial Agents)
DE59308714D1 (de) Cyclobutan-benzol-derivate
FI20002460A7 (fi) 4-difenyylimetyylipiperidiinijohdannaisia
FI935228A7 (fi) 2-alkoksi-2-imidatsoli-5-ooni-sienimyrkkyjohdannaiset
FI934082L (fi) Kitosanbaserade naerings- och laekemedelskompositioner foer idisslare
NO952288D0 (no) Benzazepinon-derivater
FI920111A7 (fi) Antibakteriaalisia aineita
DE69313890D1 (de) 5-Aminoflavon-Derivate
MX9206710A (es) Derivados de piridinol
FI930367L (fi) Puridinderivat
FI950694A7 (fi) Antimikrobinen koostumus
FI982097A7 (fi) Antibakteerisia atsaspirokinoloneja
FI930934L (fi) Tetrahydropyrimidinderivat
FI930922A7 (fi) Substituerade fenylkinazolinderivat

Legal Events

Date Code Title Description
FB36 Technical and formal requirements: requirement - article 36 of industrial property law
FC Decision: refusal
FC Decision: refusal
CKFC Appeal: appeal against refusal